Literature DB >> 8153402

Immunosuppressive drug therapy of systemic lupus erythematosus.

D A Fox1, W J McCune.   

Abstract

This article reviews the biologic effects of cyclophosphamide and azathioprine relevant to the treatment of systemic lupus erythematosus (SLE). Other agents used less commonly for SLE, such as methotrexate, chlorambucil, and cyclosporin-A, receive more limited attention. Clinical studies of efficacy and toxicity of these agents in their treatment of SLE are then described in detail.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8153402

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN： 0889-857X            Impact factor:   2.670


  12 in total

Review 1.  Combination treatment in autoimmune diseases: systemic lupus erythematosus.

Authors:  G Moroni; O Della Casa Alberighi; C Ponticelli
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Predictors of flares and long-term outcome of systemic lupus erythematosus during combined treatment with azathioprine and low-dose prednisolone.

Authors:  P Oelzner; K Abendroth; G Hein; G Stein
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

3.  Peptide inhibition of glomerular deposition of an anti-DNA antibody.

Authors:  B Gaynor; C Putterman; P Valadon; L Spatz; M D Scharff; B Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 4.  Complications of cyclophosphamide therapy.

Authors:  C A Langford
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

5.  Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-12       Impact factor: 1.925

6.  Improved survival in severe paraquat poisoning with repeated pulse therapy of cyclophosphamide and steroids.

Authors:  Ja-Liang Lin; Dan-Tzu Lin-Tan; Kuan-Hsing Chen; Wen-Hung Huang; Ching-Wei Hsu; Hsiang-Hao Hsu; Tzung-Hai Yen
Journal:  Intensive Care Med       Date:  2011-02-15       Impact factor: 17.440

7.  Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).

Authors:  Meral Calguneri; Zeynep Ozbalkan; M Akif Ozturk; Sule Apras; A Ihsan Ertenli; Sedat Kiraz
Journal:  Clin Rheumatol       Date:  2006-03-18       Impact factor: 2.980

8.  Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide.

Authors:  E M McDermott; R J Powell
Journal:  Ann Rheum Dis       Date:  1996-04       Impact factor: 19.103

9.  Severe digital necrosis in a 4-year-old boy: primary Raynaud's or jellyfish sting.

Authors:  Fatih Koksal Binnetoglu; Betul Kizildag; Naci Topaloglu; Ozgur Kasapcopur
Journal:  BMJ Case Rep       Date:  2013-11-18

10.  Experience with azathioprine in systemic sclerosis associated with interstitial lung disease.

Authors:  K Dheda; U G Lalloo; B Cassim; G M Mody
Journal:  Clin Rheumatol       Date:  2004-04-14       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.